Probing 3CL protease : Rationally designed chemical moieties for COVID-19
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
|---|---|
| Enthalten in: |
Drug development research - 81(2020), 8 vom: 18. Dez., Seite 911-918 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sharma, Mousmee [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 29.11.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1002/ddr.21724 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313052425 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313052425 | ||
| 003 | DE-627 | ||
| 005 | 20231225145735.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ddr.21724 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1043.xml |
| 035 | |a (DE-627)NLM313052425 | ||
| 035 | |a (NLM)32729640 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sharma, Mousmee |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Probing 3CL protease |b Rationally designed chemical moieties for COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Prasher, Parteek |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Meenu |e verfasserin |4 aut | |
| 700 | 1 | |a Zacconi, Flavia C |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Yogendra |e verfasserin |4 aut | |
| 700 | 1 | |a Kapoor, Deepak N |e verfasserin |4 aut | |
| 700 | 1 | |a Dureja, Harish |e verfasserin |4 aut | |
| 700 | 1 | |a Pardhi, Dinesh M |e verfasserin |4 aut | |
| 700 | 1 | |a Tambuwala, Murtaza M |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Gaurav |e verfasserin |4 aut | |
| 700 | 1 | |a Chellappan, Dinesh K |e verfasserin |4 aut | |
| 700 | 1 | |a Dua, Kamal |e verfasserin |4 aut | |
| 700 | 1 | |a Satija, Saurabh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug development research |d 1993 |g 81(2020), 8 vom: 18. Dez., Seite 911-918 |w (DE-627)NLM081794991 |x 1098-2299 |7 nnns |
| 773 | 1 | 8 | |g volume:81 |g year:2020 |g number:8 |g day:18 |g month:12 |g pages:911-918 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ddr.21724 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 81 |j 2020 |e 8 |b 18 |c 12 |h 911-918 | ||